Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

4.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.4K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Survival Analysis01:21

Cancer Survival Analysis

429
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
429

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Revealing the Physician's Task Conceptualization in Melanoma Treatment: Qualitative User Experience Study.

JMIR cancer·2026
Same author

A real-time dashboard for optimizing blood product utilization through a FHIR-based data integration pipeline.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
Same author

A Multimodal Pipeline for Clinical Data Extraction: Applying Vision-Language Models to Scans of Transfusion Reaction Reports.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

Requirements for a dashboard optimized for melanoma patient care through user-centered context exploration.

Scientific reports·2024
Same author

Use of Real-World FHIR Data Combined with Context-Sensitive Decision Modeling to Guide Sentinel Biopsy in Melanoma.

Journal of clinical medicine·2024
Same author

Mapping Patient Data to Colorectal Cancer Clinical Algorithms for Personalized Guideline-Based Treatment.

Applied clinical informatics·2020

Related Experiment Video

Updated: Aug 29, 2025

A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

12.5K

Guideline-Based Context-Sensitive Decision Modeling for Melanoma Patients.

Catharina Lena Beckmann1, Georg Lodde2, Elisabeth Livingstone2

  • 1Department of Computer Science, University of Applied Sciences and Arts Dortmund (FH Dortmund), 44227 Dortmund, Germany.

Studies in Health Technology and Informatics
|September 8, 2022
PubMed
Summary
This summary is machine-generated.

This study models clinical guidelines into a decision support tool for melanoma treatment. The system uses patient data and FHIR resources to provide context-sensitive, individualized care recommendations.

Keywords:
BPMNClinical Decision-MakingClinical PathwayClinical Practice GuidelineMalignant MelanomaPatient-Specific Modeling

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

15.9K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.5K

Related Experiment Videos

Last Updated: Aug 29, 2025

A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

12.5K
A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

15.9K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.5K

Area of Science:

  • Medical Informatics
  • Clinical Decision Support Systems
  • Oncology

Background:

  • Clinical practice guidelines and SOPs for melanoma lack direct links to patient data.
  • Unstructured text in medical guidelines hinders real-time decision-making.
  • There is a need for integrated decision support in melanoma patient care.

Purpose of the Study:

  • To develop a modeled decision support system for melanoma treatment.
  • To link clinical guidelines with patient-specific data for improved care.
  • To provide context-sensitive treatment recommendations.

Main Methods:

  • Identified decision-making passages from melanoma SOPs.
  • Represented patient data using FHIR resources.
  • Formalized the decision algorithm using BPMN modeling with FHIR annotations.
  • Validated the model with expert dermato-oncologists.

Main Results:

  • Developed a BPMN model for melanoma treatment decision support.
  • Integrated FHIR resources at each decision point for context sensitivity.
  • Demonstrated the model using sentinel lymph node excision as an example.

Conclusions:

  • Modeled guideline information can support patient-specific clinical decision-making.
  • The system offers potential for tailored treatment options, especially in metastatic settings.
  • Contextualized decision algorithms can enhance personalized melanoma care.